Navigation Links
AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles

- JMR-132 induces growth arrest or total regression when combined with docetaxel chemotherapy - JMR-132 could provide a new therapeutic approach to the treatment of early and metastatic breast cancer

"We are very pleased and encouraged with these results we have seen to date with JMR-132 which lend further credibility to our very promising oncology platform. By targeting patients suffering from breast cancer with confirmed GHRH receptor status, we believe we may increase our chances of success in future development programs with JMR-132 in this indication. This targeted approach is an additional example of personalized therapy which is becoming more and more the way of the future," said Dr. Jurgen Engel, Executive Vice President, Global R&D and COO of AEterna Zentaris.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global, pure play biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticipates", "intends", "plans", "expects", "estimates", "will," "may", "should", "approximately", and the negative or other variations of those terms or comparable terminology, are forward-looking statements. Such statements reflect management's current views, intentions, strategies and plans and are based on certain assumptions.

Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ ma
'"/>




Page: 1 2 3

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference

Post Your Comments:
(Date:11/6/2009)...NGTON, Mass., Nov. 6 DUS... a dermatology company that is developing and mark...nd other products focused on patients with common ...nt and Chief Executive Officer, will present a cor...or Summit 2009 on Tuesday, November 10, 2009 at 10...
(Date:11/6/2009)...URY, N.Y., Nov. 6 Repossessions an...ools in the third quarter of 2009 declined as comp...ssau Asset Management,s NasTrac Quarterly Index (N...ity reports for both repossessions and orderly liq...for both construction and printing equipment, offe...
(Date:11/6/2009)...NGTON, Nov. 6 America,s... working group of mid-market and smaller innovator...s about H.R. 3962, the "Affordable Health Care for...Thursday. These smaller companies fear that the c...962 will hinder their efforts to bring new medicin...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 1Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 2Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 3Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 4Palomar Successful in U S Patent Office Re Examination of Hair Removal Patent 48874 5While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 1While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 2While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 3While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 48869 4Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 1Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 2Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 3Video 3A Varicose Veins Much More Than a Cosmetic Issue Can Prove a Health Risk 12622 4
...Accera, Inc. announced today,that recent data from...,(AC- 1202) in age-associated memory impairment (A...ally meaningful effect on memory in older adults. ...the natural course of,aging, The National Institut...aints of gradual memory loss in everyday problems ...
...es for Colon Cancer Drug, CHAPEL HILL, N.C., Aug....ng the cancer drug irinotecan, and the U.S. Food a...ion guidelines to say so,according to researchers .... Irinotecan, also known by its brand name Campto... colorectal cancer, the third most common form of,...
Other Medicine Technology:Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study 2Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study 3DNA Test Predicts Harmful Effects of Cancer Drug 2
(Date:11/8/2009)...GTON, Nov. 8 Pharmaceut... Senior Vice President Ken Johnson released the fo...reform bill: ,, "We are disappointed, but not s...y millions of hardworking Americans as well as nea...sentatives who voted against the bill. ,, "Whil...
(Date:11/8/2009)...Praises House Passage of Health Care Reform Bill ...are, improve coverage for all Americans ,, BAL...: Tonight the United States House of Representati... that would strengthen Medicare for seniors and en...s millions of Americans out of affordable health c...
(Date:11/7/2009)...N, Nov. 7 The American ...ames, Director of Health at the Family Violence Pr... Service today at its semi-annual policy-making me...the highest honor the AMA House of Delegates besto...w.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...
(Date:11/7/2009)...n: "Faithful Catholics have a responsibility to vi...ate the status quo." ,, WASHINGTON, Nov. 7 ...resident Judie Brown released the following statem...upport Speaker Nancy Pelosi,s Affordable Health Ca...ent preserving the status quo for abortion is vote...
(Date:11/7/2009)... not assume that all youth will rebel, expert says...Teens are more likely to behave badly if their par... "Parents who believe they are simply being realis... prophecy," Christy Buchanan, a psychology profess...study, said in a university news release. "Negativ...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...programs can be an effective way to reduce urinary..., according to a study led by researchers at the U...er participants in the Program to Reduce Incontine... according to the study. Findings appear in the Ja...
...Jan. 28 The Foundry, LLC, a leading,medical devic...ompleted a $5M,Series A financing for its eleventh...it Rock Partners, and added two new Managing Partn...ice companies. They join,existing Managing Partner...
... 28, 2009 Motor control exercises, when performed...ignificantly reduce pain and disability in patient...w systematic review published in the January issue... performing these types of exercises are able to b...
, EAST RUTHERFORD, N.J., Jan. 28 CCA Industries, Inc. (NYSE ALTERNEXT US: CAW) announced today that the Board of Directors declared a $.11 per share dividend for the 1st Quarter ending February 28,
...n. 28 ProAssurance,Corporation (NYSE: PRA ) ann...s,have been granted in connection with its propose...A), the nation,s leading provider of professional ...ng to be,held on March 31, 2009. If approved, the ...
... Citing concerns about erosion of RN and patient ...National Nurses Organizing Committee today critici...nal Union to take over its largest California affi...in most of the hospitals where UHW represents anci...
Other Medicine News:Health News:Weight loss reduces incontinence in obese women, UCSF study shows 2Health News:The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company 2Health News:The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company 3Health News:The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company 4Health News:Report shows motor control exercises reduce persistent low-back pain 2Health News:ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company 2Health News:CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards 2
Supercassette Quick Release
...ome is of rotary retracting, self-lubricating desi.... Its robust construction makes it accurate and in...inges means that all lateral motion is controlled ... in other, lesser designs which can result in 'cha...
SureCut M3500 Fuses, Spare
SureCut M3500 Abrasive, Fine, Knife Sharpening
Medicine Products: